Enferox- Deferasirox

  • Enferox- Deferasirox 1
  • Enferox- Deferasirox 2
  • Enferox- Deferasirox 3
Product Description

Deferasirox is an oral iron-chelating agent used for the management of chronic iron overload. It binds excess iron with high affinity and facilitates its elimination, primarily through the feces, helping reduce iron accumulation associated with repeated blood transfusions or other conditions causing iron overload. The portfolio includes 125 mg, 250 mg and 500 mg dispersible tablets in packs of 28 tablets, as well as 90 mg, 180 mg and 360 mg film-coated tablets in packs of 30 tablets, providing multiple strength and dosage-form options to support individualized iron-chelation therapy according to local prescribing information.

Read more Show less

Ilko Ilac Sanayi ve Ticaret A.S

  • Country/Region:
    Türkiye
  • Founded:
    2012
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
OTC
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    Therapeutic Area: Other Therapeutic Products Therapeutic Class: Iron-Chelating Agents 
    Application Areas: Treatment of chronic iron overload associated with repeated blood transfusions and, where locally approved, iron overload in patients with non-transfusion-dependent thalassemia syndromes, subject to the approved local prescribing information.
  • Model
    Dispersible Tablet, Film Coated Tablet
  • Measured In
    piece
More specifications Fewer specifications
Sales Markets
Show more Show less

Ilko Ilac Sanayi ve Ticaret A.S

  • Country/Region:
    Türkiye
  • Founded:
    2012
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
OTC
Pharmaceutical Company (generic finished products)
View company profile

More Products from Ilko Ilac Sanayi ve Ticaret A.S (99)

  • Fentus- Levocloperastine Fendizoate

    Product Fentus- Levocloperastine Fendizoate

    Levocloperastine Fendizoate is an antitussive agent used for the symptomatic treatment of non-productive cough. It acts on the cough reflex through both peripheral and central mechanisms, helping reduce cough frequency and intensity. The product is available as an oral suspension containing 708 mg / 100 mL...
  • Griport- Paracetamol / Pseudoephedrine HCl / Chlorpheniramine Maleate

    Product Griport- Paracetamol / Pseudoephedrine HCl / Chlorpheniramine Maleate

    Paracetamol / Pseudoephedrine HCl / Chlorpheniramine Maleate is a fixed-dose combination used for the symptomatic relief of common cold and flu symptoms. Paracetamol provides analgesic and antipyretic activity, pseudoephedrine acts as a nasal decongestant, and chlorpheniramine is an antihistamine that help...
  • Alrinast - Desloratadine

    Product Alrinast - Desloratadine

    Desloratadine is a second-generation antihistamine used for the relief of symptoms associated with allergic conditions. It selectively blocks peripheral histamine H1 receptors, helping reduce symptoms such as sneezing, rhinorrhea, nasal and ocular itching, and urticaria-related itching and wheals. The port...
  • Alerinit- Levocetirizine Dihydrochloride

    Product Alerinit- Levocetirizine Dihydrochloride

    Levocetirizine Dihydrochloride is a second-generation antihistamine used for the symptomatic treatment of allergic conditions. It selectively blocks peripheral histamine H1 receptors, helping relieve symptoms such as sneezing, rhinorrhea, nasal and ocular itching, and urticaria-related itching and wheals. ...
  • Ruftan- Rupatadine Fumarate

    Product Ruftan- Rupatadine Fumarate

    Rupatadine Fumarate is a second-generation antihistamine used for the symptomatic treatment of allergic conditions. It acts as a selective peripheral histamine H1-receptor antagonist and also exhibits platelet-activating factor (PAF) antagonist activity, helping control multiple mediators involved in aller...
  • Posaten-Polystyrene Sulfonate Calcium Salt

    Product Posaten-Polystyrene Sulfonate Calcium Salt

    Polystyrene Sulfonate Calcium Salt is a cation-exchange resin used in the management of hyperkalaemia. It acts in the gastrointestinal tract by exchanging calcium ions for potassium ions, thereby promoting potassium removal through the feces and helping reduce elevated serum potassium levels. The product i...
  • Dasatinib

    Product Dasatinib

    Dasatinib is an oral tyrosine kinase inhibitor targeting BCR-ABL and other relevant kinases involved in malignant cell proliferation. It is available as 20 mg, 50 mg and 70 mg film-coated tablets in packs of 60, and as 100 mg and 140 mg film-coated tablets in packs of 30. The broad strength range supports ...
  • Erlotinib

    Product Erlotinib

    Erlotinib is an oral epidermal growth factor receptor tyrosine kinase inhibitor that helps inhibit signalling pathways associated with tumour-cell proliferation and survival. It is available as 100 mg and 150 mg tablets in packs of 30, providing strength options for standard treatment and dose adjustment r...
  • Sunitinib

    Product Sunitinib

    Sunitinib is an oral antineoplastic agent used in the treatment of selected solid tumors. It is a multi-targeted tyrosine kinase inhibitor that blocks several receptor tyrosine kinases involved in tumor cell proliferation, angiogenesis and disease progression. The product is available in 12.5 mg, 25 mg and...
  • Ruxolitinib

    Product Ruxolitinib

    Ruxolitinib is an oral Janus kinase 1 and 2 inhibitor developed to modulate abnormal JAK-STAT signalling associated with selected haematological disorders. It is available as 5 mg, 10 mg, 15 mg and 20 mg tablets in multiple pack sizes, including 14, 56 and 168 tablets depending on the strength, supporting ...
  • Sorafenib

    Product Sorafenib

    Sorafenib is an oral multikinase inhibitor targeting signalling pathways involved in tumour-cell proliferation and tumour angiogenesis. It is available as 200 mg film-coated tablets in packs of 112, designed to support the established dosing schedule used in eligible oncology patients.  Expected ...
  • Palbociclib

    Product Palbociclib

    Palbociclib is an oral, selective inhibitor of cyclin-dependent kinases 4 and 6, designed to reduce tumour-cell proliferation by controlling cell-cycle progression. It is available as 75 mg, 100 mg and 125 mg tablets in packs of 7 or 21, supporting treatment cycles and individualized dose modification.Expe...
show all 99 other products

Ilko Ilac Sanayi ve Ticaret A.S resources (2)